Evolv Technologies Holdings, Inc.·4

Mar 9, 4:07 PM ET

Ellenbogen Michael 4

4 · Evolv Technologies Holdings, Inc. · Filed Mar 9, 2026

Research Summary

AI-generated summary of this filing

Updated

Evolv (EVLV) Director Michael Ellenbogen Sells 91,771 Shares

What Happened Michael Ellenbogen, a director of Evolv Technologies Holdings, Inc. (EVLV), reported the sale of 91,771 shares on March 6, 2026. The shares were disposed at a weighted average price of $5.10 per share, for total proceeds of about $468,032. This was a sale (not a purchase), and was executed under a prearranged Rule 10b5-1 trading plan.

Key Details

  • Transaction date: March 6, 2026; Form 4 filed March 9, 2026 (within the SEC’s filing deadline).
  • Price: weighted average $5.10; individual trades ranged from $5.04 to $5.17 (reporting person can provide a per-price breakdown on request).
  • Shares sold: 91,771; proceeds ≈ $468,032.
  • Shares owned after transaction: not specified in the supplied filing.
  • Footnotes: F1 — sale effected pursuant to a Rule 10b5-1 plan entered June 12, 2025. F2 — price is a weighted average across multiple transactions; breakdown available upon request.

Context Sales under a 10b5-1 plan are pre-scheduled and often reflect routine liquidity or diversification rather than a timely statement about the company’s prospects. This report reflects a straightforward open-market disposition by an insider; no option exercises, gifts, or special tax-withholding transactions were indicated.

Insider Transaction Report

Form 4
Period: 2026-03-06
Transactions
  • Sale

    Class A Common Stock

    [F1][F2]
    2026-03-06$5.10/sh91,771$468,0322,083,961 total
Holdings
  • Class A Common Stock

    (indirect: By Trust)
    151,135
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.04 to $5.17. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Rachel Roy, Attorney-in-fact for Michael Ellenbogen|2026-03-09

Documents

1 file
  • 4
    wk-form4_1773086843.xmlPrimary

    FORM 4